| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acquired amegakaryocytic thrombocytopenic purpura possibly induced by anti-PD-1 antibody
|
Iyama, Satoshi
|
|
|
99 |
7 |
p. 1669-1670
|
article
|
| 2 |
A novel NAP1L4/NUTM1 fusion arising from translocation t(11;15)(p15;q12) in a myeloid neoplasm with eosinophilia and rearrangement of PDGFRA highlights an unusual clinical feature and therapeutic reaction
|
Cheng, Zhao
|
|
|
99 |
7 |
p. 1561-1564
|
article
|
| 3 |
Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
|
Stemler, Jannik
|
|
|
99 |
7 |
p. 1429-1440
|
article
|
| 4 |
Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19
|
Albiol, Nil
|
|
|
99 |
7 |
p. 1673-1674
|
article
|
| 5 |
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
|
Schrezenmeier, Hubert
|
|
|
99 |
7 |
p. 1505-1514
|
article
|
| 6 |
Comparison of central nervous system relapse outcomes following haploidentical vs identical-sibling transplant for acute lymphoblastic leukemia
|
Chen, Qi
|
|
|
99 |
7 |
p. 1643-1653
|
article
|
| 7 |
Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
|
Caocci, Giovanni
|
|
|
99 |
7 |
p. 1675-1676
|
article
|
| 8 |
COVID-19 infection associated with autoimmune hemolytic anemia
|
Capes, Antoine
|
|
|
99 |
7 |
p. 1679-1680
|
article
|
| 9 |
Dynamics of hematopoiesis is disrupted by impaired hematopoietic microenvironment in a mouse model of hemophagocytic lymphohistiocytosis
|
Tsuboi, Isao
|
|
|
99 |
7 |
p. 1515-1523
|
article
|
| 10 |
Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country
|
García-Morín, Marina
|
|
|
99 |
7 |
p. 1465-1474
|
article
|
| 11 |
Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia
|
Sales, Rahyssa Rodrigues
|
|
|
99 |
7 |
p. 1453-1463
|
article
|
| 12 |
Genotypic-phenotypic heterogeneity of δβ-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India
|
Hariharan, Priya
|
|
|
99 |
7 |
p. 1475-1483
|
article
|
| 13 |
Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation
|
Kaito, Satoshi
|
|
|
99 |
7 |
p. 1655-1665
|
article
|
| 14 |
Hematological findings in coronavirus disease 2019: indications of progression of disease
|
Liu, Xiaoqing
|
|
|
99 |
7 |
p. 1421-1428
|
article
|
| 15 |
Hematological malignancies in Ukraine in post-Chernobyl era: sources of data and their preliminary analysis
|
Koval, Stella V.
|
|
|
99 |
7 |
p. 1543-1550
|
article
|
| 16 |
Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis—a dangerous disease
|
Jin, Zhili
|
|
|
99 |
7 |
p. 1575-1581
|
article
|
| 17 |
Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study
|
Chen, Zesong
|
|
|
99 |
7 |
p. 1485-1491
|
article
|
| 18 |
Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study
|
Zerbit, Jeremie
|
|
|
99 |
7 |
p. 1615-1625
|
article
|
| 19 |
LPS-induced expression and release of monocyte tissue factor in patients with haemophilia
|
Holstein, Katharina
|
|
|
99 |
7 |
p. 1531-1542
|
article
|
| 20 |
Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders
|
Watanabe, Mizuki
|
|
|
99 |
7 |
p. 1565-1573
|
article
|
| 21 |
Modern management of splenomegaly in patients with myelofibrosis
|
Tremblay, Douglas
|
|
|
99 |
7 |
p. 1441-1451
|
article
|
| 22 |
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia
|
Becker, Heiko
|
|
|
99 |
7 |
p. 1551-1560
|
article
|
| 23 |
Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab
|
Kang, Ka-Won
|
|
|
99 |
7 |
p. 1493-1503
|
article
|
| 24 |
Outcome of stem cell transplantation for Waldenström’s macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group
|
Sakurai, Masatoshi
|
|
|
99 |
7 |
p. 1635-1642
|
article
|
| 25 |
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life
|
Sortais, Clara
|
|
|
99 |
7 |
p. 1595-1604
|
article
|
| 26 |
R-CHOP appears to be the best first-line treatment for second primary diffuse large B cell lymphoma: a cancer registry study
|
Systchenko, T.
|
|
|
99 |
7 |
p. 1605-1613
|
article
|
| 27 |
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors
|
Mulas, Olga
|
|
|
99 |
7 |
p. 1525-1530
|
article
|
| 28 |
Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group
|
Muntañola, A.
|
|
|
99 |
7 |
p. 1627-1634
|
article
|
| 29 |
Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF–producing multiple myeloma
|
Kikuchi, Taku
|
|
|
99 |
7 |
p. 1667-1668
|
article
|
| 30 |
SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone
|
Visani, Giuseppe
|
|
|
99 |
7 |
p. 1677-1678
|
article
|
| 31 |
The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)
|
Janikova, Andrea
|
|
|
99 |
7 |
p. 1583-1594
|
article
|
| 32 |
Uterine myeloid sarcoma
|
Martino, Giovanni
|
|
|
99 |
7 |
p. 1671-1672
|
article
|
Journal description